A guide to murine coagulation factor structure, function, assays, and genetic alterations
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (4) , 670-679
- https://doi.org/10.1111/j.1538-7836.2007.02408.x
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Versican G3 Domain Promotes Blood Coagulation through Suppressing the Activity of Tissue Factor Pathway Inhibitor-1Journal of Biological Chemistry, 2006
- Extraembryonic expression of EPCR is essential for embryonic viabilityBlood, 2005
- Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneBlood, 2004
- Neonatal bleeding and decreased plasma fibrinogen levels in mice modeled after the dysfibrinogen Vlissingen/Frankfurt IVJournal of Thrombosis and Haemostasis, 2004
- Antibody blockade or mutation of the fibrinogen γ-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogenBlood, 2004
- Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiencyBlood, 2004
- Mouse models in haemostasis and thrombosisThrombosis and Haemostasis, 2004
- The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasisBlood, 2003
- Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.Journal of Clinical Investigation, 1998
- Characterization of the Murine Plasma Fibrinolytic SystemEuropean Journal of Biochemistry, 1994